Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: A pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 10, 2013, Pages 1622-1624

  Basu, Sandip ^a   Kand, Purushottam ^a   Mallia, Madhav ^b   Korde, Aruna ^b   Shimpi, Hemant ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 68; HYNIC TOC TC 99M; LUTETIUM 177; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TETRAXETAN OCTREOTATE LU177; TETRAXETAN TATE GA68; UNCLASSIFIED DRUG;

CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INDIA; LETTER; NUCLEAR ENERGY; POPULATION DENSITY; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIAL STATUS;

HUMANS; INDIA; OCTREOTIDE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REAGENT KITS, DIAGNOSTIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84885468424     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2501-0     Document Type: Letter

References (1)

1. Guggenberg EV, Mikolajczak R, Janota B, Riccabona G, Decristoforo C. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]-octreotide, a somatostatin analog for tumor diagnosis. J Pharm Sci. 2004;93(10):2497-506.